Answers are grounded in this paper and cite their sources.
Observational analysis of treatment strategies for exocrine pancreatic insufficiency in children, indicating potential improvements in nutritional outcomes.
Exocrine pancreatic insufficiency (EPI) is a common clinical condition in both children and adults, characterized by malabsorption, nutritional deficiencies, and reduced quality of life. The aim - to review modern approaches to diagnosis and enzyme replacement therapy for EPI. In pediatric practice, the leading causes of EPI include cystic fibrosis, chronic pancreatitis, congenital genetic syndromes, celiac disease, and postoperative conditions involving the gastrointestinal tract. Early diagnosis is based on clinical symptoms, laboratory markers (particularly fecal elastase-1), and comprehensive nutritional assessment. Pancreatic enzyme replacement therapy (PERT) remains the cornerstone of EPI management. Its effectiveness depends on individualized dosing, timing of enzyme intake, and appropriate dietary support. In cases of persistent symptoms despite PERT, it is essential to evaluate dosage adequacy, administration regimen, and the presence of comorbid gastrointestinal disorders. This article summarizes current European and North American guidelines on PERT use in children, offering practical recommendations for clinicians. No conflict of interest was declared by the authors.
No takes yet. Share an insight, caveat, or question.
Nyankovska et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: